Home / Stocks / KLRS

KLRS insider trading

Kalaris Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$6.2M
Buys · last 90 days
0 · $0
Most recent buy
2026-05-22

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-05-22AKKARAJU SRINIVAS
Director · 10% owner
Bought244,300$4.83$1.2M
2026-02-17AKKARAJU SRINIVAS
Director · 10% owner
Bought479,847$10.42$5.0M

Most active insider buyers

InsiderRoleBuysTotal bought
AKKARAJU SRINIVASDirector · 10% owner2$6.2M

See KLRS on the chart

Every insider buy and sell for KLRS plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.